[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-1-en-105":3,"doc-seo-571471-105":53,"doc-detail-571471-en":127},{"code":4,"msg":5,"data":6},0,"success",[7,14,19,24,29,34,39,44,49],{"id":8,"doc_module":9,"doc_module_name":10,"category_name":11,"show_sort_weight":12,"slug":13},11,1,"Template","Presentations",90,"presentations",{"id":15,"doc_module":9,"doc_module_name":10,"category_name":16,"show_sort_weight":17,"slug":18},12,"Resumes",80,"resumes",{"id":20,"doc_module":9,"doc_module_name":10,"category_name":21,"show_sort_weight":22,"slug":23},14,"Invoices",70,"invoices",{"id":25,"doc_module":9,"doc_module_name":10,"category_name":26,"show_sort_weight":27,"slug":28},15,"Posters",60,"posters",{"id":30,"doc_module":9,"doc_module_name":10,"category_name":31,"show_sort_weight":32,"slug":33},16,"Social Media",50,"social-media",{"id":35,"doc_module":9,"doc_module_name":10,"category_name":36,"show_sort_weight":37,"slug":38},17,"Forms",40,"forms",{"id":40,"doc_module":9,"doc_module_name":10,"category_name":41,"show_sort_weight":42,"slug":43},18,"Letters",30,"letters",{"id":45,"doc_module":9,"doc_module_name":10,"category_name":46,"show_sort_weight":47,"slug":48},21,"Paper Templates",5,"papers-templates",{"id":50,"doc_module":9,"doc_module_name":10,"category_name":51,"show_sort_weight":4,"slug":52},158,"General","general-158",{"code":4,"msg":54,"data":55},"ok",{"site_id":56,"language":57,"slug":58,"title":59,"keywords":60,"description":61,"schema_data":62,"social_meta":120,"head_meta":122,"extra_data":124,"updated_unix":126},105,"en","peptide-ratios-and-mixdowns-recommended-doses-and-injection-notes","Peptide Ratios and Mixdowns - Recommended Doses and Injection Notes","","Compilation of peptide product guidance organized by active ingredients, including vial amount, diluent amount, per-unit concentration, and recommended dose ranges. For each peptide, it specifies frequency schedules (daily, weekly, or multi-day cycles), injection route such as subcutaneous or intramuscular, and dosing limits or caution notes. Content also includes intended effects like anti-inflammatory action, mitochondrial support, DNA repair, mood and libido effects, and skin/wound healing claims, plus mixture guidance for defined unit counts.",{"@graph":63,"@context":119},[64,80,102],{"@type":65,"itemListElement":66},"BreadcrumbList",[67,71,74,77],{"item":68,"name":69,"@type":70,"position":9},"https://docshare.wps.com","Home","ListItem",{"item":72,"name":10,"@type":70,"position":73},"https://docshare.wps.com/template/",2,{"item":75,"name":51,"@type":70,"position":76},"https://docshare.wps.com/template/general/",3,{"item":78,"name":59,"@type":70,"position":79},"https://docshare.wps.com/template/peptide-ratios-and-mixdowns-recommended-doses-and-injection-notes/571471/",4,{"url":78,"name":59,"@type":81,"image":82,"author":87,"headline":59,"publisher":90,"fileFormat":93,"inLanguage":57,"description":61,"dateModified":94,"datePublished":95,"encodingFormat":93,"isAccessibleForFree":96,"interactionStatistic":97},"DigitalDocument",{"url":83,"@type":84,"width":85,"height":86},"https://docshare.wps.com/thumbnails/peptide-ratios-and-mixdowns-recommended-doses-and-injection-notes/571471.png","ImageObject",442,249,{"name":88,"@type":89},"nayy☆","Person",{"url":68,"name":91,"@type":92},"DocShare","Organization","application/pdf","2026-10-23","2026-10-13",true,{"@type":98,"interactionType":99,"userInteractionCount":101},"InteractionCounter",{"@type":100},"ViewAction",8,{"@type":103,"mainEntity":104},"FAQPage",[105,111,115],{"name":106,"@type":107,"acceptedAnswer":108},"What information is provided for each peptide in the document?","Question",{"text":109,"@type":110},"Each section lists vial amount and BAC water, concentration per unit, recommended dose range, and a dosing frequency schedule. It also includes injection type and additional notes such as limits or usage timing.","Answer",{"name":112,"@type":107,"acceptedAnswer":113},"Which injection routes are mentioned?",{"text":114,"@type":110},"The document specifies injection type such as subcutaneous and intramuscular, and includes notes where certain options are oral/tablet-based (N/A).",{"name":116,"@type":107,"acceptedAnswer":117},"How are dosing schedules and unit counts described?",{"text":118,"@type":110},"Schedules are written as ranges (e.g., daily, twice per week, or multi-cycle periods) and often tied to unit counts like 50–100 units or 10–30 units, depending on the peptide section.","https://schema.org",{"og:url":78,"og:type":121,"og:title":59,"og:site_name":91,"og:description":61},"article",{"robots":123,"canonical":78},"index,follow",{"doc_id":125,"site_id":56},571471,1792087001,{"code":4,"msg":5,"data":128},{"doc_id":125,"user_id":129,"nickname":88,"user_avatar":130,"doc_module":9,"category_id":50,"category_name":51,"doc_title":59,"doc_description":61,"doc_content":131,"file_id":132,"file_url":133,"file_type":134,"file_size":135,"view_count":101,"is_deleted":4,"is_public":9,"is_downloadable":9,"audit_status":9,"page_count":136,"language":137,"language_code":57,"site_id":56,"html_lang":57,"table_of_contents":138,"faqs":139,"seo_title":140,"seo_description":61,"update_tm":141,"read_time":142},962090893153,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","3/21/25,2:48 PM  \nAlpha  \nBioMed  \nAlpha  \nHEALING AND REPAIR  \nBioMed  \nDECREASES INFLAMMATION-BINDS TO ACTIN CREATINGFASTER HEALING TIME-ACCELERATES WOUND HEALINGOF JOINTS AND MUSCLES  \nAMOUNT IN VIALBACWATER INAMOUNT PER UNIT  \n10MG  \n1ML  \n0.1MG PER UNIT  \nX  \nRECOMBENDED DOSEFREQUENCY  \n2.5 TO 5MG  \nTWICE PER WEEK  \n(25 TO 50 UNITS)  \nNOTES:  \nINJECTION TYPE:  \nSUBCUTANEOUS  \nWORKS IN SYNERGY WITH BPC-157  \n3/21/25,2:50 PM  \n三  \n# \"EXERCISE INA BOTTLE\"-TURNS AVAILABLE GLUCOSEINTO ENERGY IN THE MITOCHONDRIA-ANTI AGING-USEDTO HELP TYPE 2 DIABETES AND INSULIN RESISTANCE\n\nAMOUNT IN VIAL  \nBACWATER IN  \n10MG  \n1ML  \nX  \n# RECOMMENDED DOSEFREQUENCY\n\n1 INJECTION EVERY  \n5MG -10MG  \n5 DAYS FOR 20 DAYS  \n(50 UNITS-100 UNITS)  \nNOTES:  \nINJECTION TYPE:  \nSUBCUTANEOUS  \n3X ANNUALLY  \n**IF TYPE 2 DIABETIC,1MG EOD TO LOWERBLOOD SUGARS  \n***LOWER DOSE 5MG (50 UNITS)WILL.REQUIRE 2HE CYCLE  \n三10MG(100 UNITS)WILLnLuuinL-uufTLES FOR THE CYCLE  \n# MITOCHONDRIAL FUNCTION\n\nAMOUNT PER UNIT  \n0.1MG PER UNIT  \n3/21/25,2:51 PM  \n三  \n# DNA REPAIR-RESTORE CELLULAR DAMAGE-HELPSCONVERT NUTRIENTS INTOATP-ENHANCESMITOCHONDRIAL FUNCTION\n\n1000MG  \n2ML  \nRECOMMENDED DOSEFREQUENCY  \n50MG TO 150MG10 UNITS DAILY OR(10 TO 30 UNITS)20-30 UNITS 2X PER WEEK  \nNOTES:  \nINJECTION TYPE:  \nINTRAMUSCULAR  \nSINGLE DOSE NOT TOEXCEED 250MG(50 UNITS)  \n5MG PER UNIT  \nX  \n吕  \nBRAIN+MOOD  \nAMOUNT IN VIALBAC WATER INANOUNT PER UNTT  \n3/21/25,2:51 PM  \nAlpha  \n三  \nBioMed  \n# ◎XYTOCIN\n\nKNOWN AS THE \"LOVE HORMONE\"-INCREASES SOCIALBONDING AND EMOTIONAL WELL BEING-HELPS WITHSTRESS AND ANXIETY  \nAMOUNT IN VIALBACWATER INAMOUNT PER UNT  \n5MG  \n0.05MG PER UNIT  \nX  \n1ML  \nRECOMMENDED DOSE  \nFREQUENCY  \n250MCG TO 500MCG(5 TO 10 UNITS)  \nDAILY  \nNOTES:  \nINJECTION TYPE:  \nSUBCUTANEOUS  \nBRAIN+MOOD  \n三  \nAlpha  \nBioMed  \n◎XYTOCIN  \nKNOWN AS THE \"LOVE HORMONE\"-INCREASES SOCIALBONDING AND EMOTIONAL WELL BEING-HELPS WITHSTRESS AND ANXIETY  \nAMOUNTIN VIALBACWATER INAMOUNT PER UNITT10MGX2ML0.05MG PER UNIT  \nRECOMMENDED DOSEFREGUENCY  \n250MCG TO 500MCG(5 TO 10 UNITS)  \nDAILY  \nNOTES:  \nINJECTION TYPE:  \nSUBCUTANEOUS  \nBRAIN+MOOD  \n3/21/25,2:52 PM  \n# TESOFENSINE\n\n÷  \n50MG  \nRECOMNENDED DOSE  \n250MCG TO 1000MCG(1/2 TO4 TABLETS  \nNOTES:  \nINJECTION TYPE:N/A(ORAL TABLETS)  \nFASTED UPON WAKING  \nAlpha  \nBioMed  \nSERATONIN,NORADRENALINE,DOPAMINE,REUPTAKEINHiBITOR(SNDRI)-ENHANCE MOOD-SUPRESSAPPETITE-INCREASED ENERGY-COGNITIVE FUNCTION  \nAMOUNT IN BOTTLE TOTALTABLETSAMOUNT PER TABLET  \n500MCG  \n100  \nFREQUENCY  \nDAILY  \nBRAIN+WEIGHTLOSS  \n3/21/25,2:53 PM  \n三  \nAlpha  \nBioMed  \nPT-141  \nSIGNALS CENTRAL NERVOUS SYSTEM TOENHANCE BLOOD FLOW,AROUSAL ANDLIBIDO IN MEN AND WOMEN  \nAMOUNT IN VIALBACWATER INAMOUNT PER UNTT  \nRECOMMENDED DOSEFREQUENCY  \nAS NEEDED (2 HOURSBEFORE SEXUAL ACTIVITY)  \n500MCG TO 1MG  \n(10 TO 20 UNITS)  \nNOTES:  \nINJECTION TYPE:  \nSUBCUTANEOUS  \nNOT TO EXCEED 20 UNITS(CONSULT WITH DOCTOR)  \n10MGX2 ML0.05MG PER UNIT  \n吕  \nQ  \nLIBIDO/ED  \n3/21/25,2:54 PM  \n三  \nAlpha  \nHAIR/SKIN/COLLAGEN  \nBioMed  \n# GHK-Cu\n\nTIGHTENS LOOSE SKIN-REDUCES FINE LINES AND  \nWRINKLES-FIGHTS HAIR LOSS-WOUND HEALING-  \nBONE REPAIR-FIGHTS INFLAMMATION  \nAMOUNT IN VIAL8ACWATER INAMOUNT PER UNTT  \n50MG  \nX  \n0.25MG PER UNIT  \n2ML  \nRECOMBENDED DOSE  \nFRECUENCY  \n1MG TO 2MG  \nDAILY  \n(4 TO 8 UNITS)  \nNOTES:  \nINJECTION TYPE:  \nSUBCUTANEOUS  \n30 DAYS ON/14 DAYS OFF  \n3/21/25,2:54 PM  \n三  \n吕  \nHAIR/SKIN/COLLAGEN  \nGHK-Cu  \nTIGHTENS LOOSE SKIN-REDUCES FINE LINES AND  \nWRINKLES-FIGHTS HAIR LOSS-WOUND HEALING-  \nBONE REPAIR-FIGHTS INFLAMMATION  \nAMOUNT IN VIALBACWATER INAMOUNT PER UNIT  \n75MGX2ML0.375MG PER UNIT  \nRECOMMENDED DOSE  \nFREQUENCY  \n1MG TO 2MG  \nDAILY  \n(3 TO5 UNITS)  \n# NOTES:\n\nINJECTION TYPE:SUBCUTANEOUS30 DAYS ON/14 DAYS OFF  \n3/21/25,2:55 PM  \nTA-1 COMPLEX  \nTHYMOSIN ALPHA-1  \nSTIMULATES IMMUNE SYSTEM-PRDUCING AND ACTIVATINGT-CELLS,DENDRITIC CELLS,AND NATURAL KILLER CELLS-ERADICATES BACTERIA,FUNGI AND VIRUSES  \n16.4MG  \nX  \nRECOMMENDED DOSEFREQUENCY  \n3MG TO 8MG  \n(20-50 UNITS)  \nNOTES:  \nINJECTION TYP","cbCaimDoes4ep7vE","https://ap.wps.com/l/cbCaimDoes4ep7vE","pdf",6705488,29,"English","# Peptide dosing and mixdown notes\n## Alpha BioMed peptides and vial ratios\n## Recommended dose frequency and injection types\n## Condition-specific notes (e.g., type 2 diabetes, mood/libido)\n## Selected peptides and claimed functions","[{\"question\":\"What information is provided for each peptide in the document?\",\"answer\":\"Each section lists vial amount and BAC water, concentration per unit, recommended dose range, and a dosing frequency schedule. It also includes injection type and additional notes such as limits or usage timing.\"},{\"question\":\"Which injection routes are mentioned?\",\"answer\":\"The document specifies injection type such as subcutaneous and intramuscular, and includes notes where certain options are oral/tablet-based (N/A).\"},{\"question\":\"How are dosing schedules and unit counts described?\",\"answer\":\"Schedules are written as ranges (e.g., daily, twice per week, or multi-cycle periods) and often tied to unit counts like 50–100 units or 10–30 units, depending on the peptide section.\"}]","Peptide Ratios and Mixdowns - Recommended Doses and Injection Notes | PDF",1791919338,10]